Globus Medical Partners with the UK’s NHS to Provide Hospitals with Surgical Robotic Navigation Technology

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

First Robotic Assisted Spine Surgeries Performed at Two NHS Trust Hospitals with Globus Medical’s ExcelsiusGPS®

AUDUBON, Pa., Nov. 17, 2022 (GLOBE NEWSWIRE) — The NHS and Globus Medical have partnered to provide state-of-the-art robotic navigation technology for spinal surgery to NHS hospitals across the United Kingdom. This partnership will allow NHS Trust hospitals to seamlessly implement the ExcelsiusGPS® robotic assisted spine system into operating theatres, providing patients and surgeons with leading technology.

Oxford University Hospitals NHS Foundation Trust was the first to purchase ExcelsiusGPS® in April 2022, and the first to perform clinical cases.

Following shortly after, The Walton Centre NHS Foundation Trust Liverpool collaborated with NHS Procurement to allow all NHS hospitals to access this technology. The Walton Centre purchased their own ExcelsiusGPS® system in early October and began cases immediately.

Colin Nnadi, Orthopedic Surgeon at Oxford University Hospitals, commented, “We are exceptionally proud of the acquisition of this new technology, which will improve the quality of spinal surgery carried out in the Trust.”

Chief Executive Jan Ross at The Walton Centre Liverpool said, “This exciting new innovation is going to change the face of spinal surgery here at The Walton Centre and beyond. Our surgeons have already successfully operated on patients with the ExcelsiusGPS® robotic navigation system and are planning to apply the benefits of this new technology to many more procedures. The team has worked incredibly hard to get this project across the line, and they are pioneering how spinal operations can be modernised for the NHS going forward. This system will mean a more efficient service for our patients.” 

ExcelsiusGPS®, the world’s first revolutionary robotic navigation platform, is designed to improve safety, accuracy, and efficiency in the operating theatre. By adopting Globus Medical’s groundbreaking technology, Oxford University Hospitals and The Walton Centre Liverpool are continuing to lead the way in spinal surgery and to advance patient care.

Jay Martin, President of Imaging, Navigation, and Robotics at Globus Medical, commented that the partnership “is a significant milestone for both Globus Medical and the NHS to fundamentally change the future of spine surgery in the UK.”

About ExcelsiusGPS®
ExcelsiusGPS® provides improved visualization of patient anatomy in spine and cranial applications, throughout the procedure to help optimize patient treatment. The system is designed to streamline the surgical workflow and to reduce radiation exposure to surgeons and staff. This revolutionary robotic navigation platform is the world’s first technology to combine a rigid robotic arm and full navigation capabilities into one adaptable platform for accurate trajectory alignment in spine surgery. ExcelsiusGPS® is Globus Medical’s advanced technology solution designed to enhance safety and improve efficiency for patients, staff and surgeons in the operating room.

About Globus Medical, Inc. 
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com

Contact: 
Brian Kearns 
Senior Vice President, Business Development and Investor Relations 
Phone: (610) 930-1800 
Email:  investors@globusmedical.com
www.globusmedical.com

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

14 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

14 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

17 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

17 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

17 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

17 hours ago